Cargando…
Progress and controversies in developing cancer vaccines
Immunotherapy has become a standard approach for cancer management, through the use of cytokines (eg: interleukin-2) and monoclonal antibodies. Cancer vaccines hold promise as another form of immunotherapy, and there has been substantial progress in identifying shared antigens recognized by T cells,...
Autores principales: | Slingluff, Craig L, Speiser, Daniel E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142519/ https://www.ncbi.nlm.nih.gov/pubmed/15862126 http://dx.doi.org/10.1186/1479-5876-3-18 |
Ejemplares similares
-
Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines
por: Lasco, Gideon, et al.
Publicado: (2021) -
Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009) -
Controversies in enhanced recovery after cardiac surgery
por: Shaw, Andrew D., et al.
Publicado: (2022) -
Roundtable debate: Controversies in the management of the septic patient – desperately seeking consensus
por: Waxman, Aaron B, et al.
Publicado: (2005) -
Airway Surface Liquid: End of the Controversy?
por: Landry, Jennifer S., et al.
Publicado: (2001)